These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11243687)
41. Interference of maternal antibodies with the immune response of foals after vaccination against equine influenza. van Maanen C; Bruin G; de Boer-Luijtze E; Smolders G; de Boer GF Vet Q; 1992 Jan; 14(1):13-7. PubMed ID: 1574831 [TBL] [Abstract][Full Text] [Related]
42. Facing the threat of equine influenza. Elton D; Bryant N Equine Vet J; 2011 May; 43(3):250-8. PubMed ID: 21492200 [TBL] [Abstract][Full Text] [Related]
43. Maternal antibodies against equine influenza virus in foals and their interference with vaccination. Van Oirschot JT; Bruin G; de Boer-Luytze E; Smolders G Zentralbl Veterinarmed B; 1991 Jul; 38(5):391-6. PubMed ID: 1656657 [TBL] [Abstract][Full Text] [Related]
44. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889 [TBL] [Abstract][Full Text] [Related]
45. Vaccine failure caused an outbreak of equine influenza in Croatia. Barbic L; Madic J; Turk N; Daly J Vet Microbiol; 2009 Jan; 133(1-2):164-71. PubMed ID: 18632226 [TBL] [Abstract][Full Text] [Related]
46. Risk factors for equine influenza serum antibody titres in young thoroughbred racehorses given an inactivated vaccine. Newton JR; Lakhani KH; Wood JL; Baker DJ Prev Vet Med; 2000 Jul; 46(2):129-41. PubMed ID: 10878300 [TBL] [Abstract][Full Text] [Related]
47. Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine. Kannegieter NJ; Frogley A; Crispe E; Kirkland PD Aust Vet J; 2011 Jul; 89 Suppl 1():139-42. PubMed ID: 21711313 [TBL] [Abstract][Full Text] [Related]
48. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Nelson KM; Schram BR; McGregor MW; Sheoran AS; Olsen CW; Lunn DP Vaccine; 1998 Aug; 16(13):1306-13. PubMed ID: 9682395 [TBL] [Abstract][Full Text] [Related]
49. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus. Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066 [TBL] [Abstract][Full Text] [Related]
50. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge. Pouwels HG; Van de Zande SM; Horspool LJ; Hoeijmakers MJ Vet Rec; 2014 Jun; 174(25):633. PubMed ID: 24795071 [TBL] [Abstract][Full Text] [Related]
51. Positive results in a real-time PCR for type A influenza associated with the use of an inactivated vaccine. Diallo I; Read AJ; Kirkland PD Aust Vet J; 2011 Jul; 89 Suppl 1():145-6. PubMed ID: 21711315 [TBL] [Abstract][Full Text] [Related]
52. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study. Daly JM; Sindle T; Tearle J; Barquero N; Newton JR; Corning S Equine Vet J; 2007 Sep; 39(5):446-50. PubMed ID: 17910270 [TBL] [Abstract][Full Text] [Related]
53. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474 [TBL] [Abstract][Full Text] [Related]
55. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013. Kim EJ; Kim BH; Yang S; Choi EJ; Shin YJ; Song JY; Shin YK J Vet Med Sci; 2015 Nov; 77(11):1517-21. PubMed ID: 26062436 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of a whole inactivated EI vaccine against a recent EIV outbreak isolate and comparative detection of virus shedding. Paillot R; Prowse L; Donald C; Medcalf E; Montesso F; Bryant N; Watson J; Jeggo M; Elton D; Newton R; Trail P; Barnes H Vet Immunol Immunopathol; 2010 Aug; 136(3-4):272-83. PubMed ID: 20400185 [TBL] [Abstract][Full Text] [Related]
57. Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines--a retrospective analysis of three independent field trials. Heldens JG; Weststrate MW; van den Hoven R J Immunol Methods; 2002 Jun; 264(1-2):11-7. PubMed ID: 12191504 [TBL] [Abstract][Full Text] [Related]
58. Efforts to pre-empt an equine influenza epidemic. Mumford J; Cardwell J; Daly J; Newton R Vet Rec; 2003 Mar; 152(13):405-6. PubMed ID: 12696710 [No Abstract] [Full Text] [Related]
59. Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Mumford JA; Wilson H; Hannant D; Jessett DM Epidemiol Infect; 1994 Apr; 112(2):421-37. PubMed ID: 8150017 [TBL] [Abstract][Full Text] [Related]
60. Cross-reactivity of existing equine influenza vaccines with a new strain of equine influenza virus from China. Chambers TM Vet Rec; 1992 Oct; 131(17):388-91. PubMed ID: 1333665 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]